scholarly journals GAD: a Python script for dividing genome annotation files into feature-based files

2019 ◽  
Author(s):  
Ahmed Karam ◽  
Norhan Yasser

AbstractNowadays, manipulating and analyzing publicly available genomic datasets become a daily task in bioinformatics and genomics laboratories. The release of several genome sequencing projects prompts bioinformaticians to develop automated scripts and pipelines which analyze genomic datasets in particular gene annotation pipelines. Handling genome annotation files with fully-featured programs used by non-developers is necessary, furthermore, accelerating genomic data analysis with a focus on diminishing the genome annotation and sequence files based on specific features is required. Consequently, to extract genome features from GTF or GFF3 in a precise manner, GAD script (https://github.com/bio-projects/GAD) provides a simple graphical user interface which interpreted by all python versions installed in different operating systems. GAD script contains unique entry widgets which are capable to analyze multiple genome sequence and annotation files by a click. With highly influential coded functions, genome features such upstream genes, downstream genes, intergenic regions, genes, transcripts, exons, introns, coding sequences, five prime untranslated regions, and three prime untranslated regions and other ambiguous sequence ontology terms will be extracted. GAD script outputs the results in diverse file formats such as BED, GTF/GFF3 and FASTA files which supported by other bioinformatics programs. Our script could be incorporated into various pipelines in all genomics laboratories with the aim of accelerating data analysis.

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Zeeshan Ahmed ◽  
Eduard Gibert Renart ◽  
Saman Zeeshan ◽  
XinQi Dong

Abstract Background Genetic disposition is considered critical for identifying subjects at high risk for disease development. Investigating disease-causing and high and low expressed genes can support finding the root causes of uncertainties in patient care. However, independent and timely high-throughput next-generation sequencing data analysis is still a challenge for non-computational biologists and geneticists. Results In this manuscript, we present a findable, accessible, interactive, and reusable (FAIR) bioinformatics platform, i.e., GVViZ (visualizing genes with disease-causing variants). GVViZ is a user-friendly, cross-platform, and database application for RNA-seq-driven variable and complex gene-disease data annotation and expression analysis with a dynamic heat map visualization. GVViZ has the potential to find patterns across millions of features and extract actionable information, which can support the early detection of complex disorders and the development of new therapies for personalized patient care. The execution of GVViZ is based on a set of simple instructions that users without a computational background can follow to design and perform customized data analysis. It can assimilate patients’ transcriptomics data with the public, proprietary, and our in-house developed gene-disease databases to query, easily explore, and access information on gene annotation and classified disease phenotypes with greater visibility and customization. To test its performance and understand the clinical and scientific impact of GVViZ, we present GVViZ analysis for different chronic diseases and conditions, including Alzheimer’s disease, arthritis, asthma, diabetes mellitus, heart failure, hypertension, obesity, osteoporosis, and multiple cancer disorders. The results are visualized using GVViZ and can be exported as image (PNF/TIFF) and text (CSV) files that include gene names, Ensembl (ENSG) IDs, quantified abundances, expressed transcript lengths, and annotated oncology and non-oncology diseases. Conclusions We emphasize that automated and interactive visualization should be an indispensable component of modern RNA-seq analysis, which is currently not the case. However, experts in clinics and researchers in life sciences can use GVViZ to visualize and interpret the transcriptomics data, making it a powerful tool to study the dynamics of gene expression and regulation. Furthermore, with successful deployment in clinical settings, GVViZ has the potential to enable high-throughput correlations between patient diagnoses based on clinical and transcriptomics data.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Michael F. Z. Wang ◽  
Madhav Mantri ◽  
Shao-Pei Chou ◽  
Gaetano J. Scuderi ◽  
David W. McKellar ◽  
...  

AbstractConventional scRNA-seq expression analyses rely on the availability of a high quality genome annotation. Yet, as we show here with scRNA-seq experiments and analyses spanning human, mouse, chicken, mole rat, lemur and sea urchin, genome annotations are often incomplete, in particular for organisms that are not routinely studied. To overcome this hurdle, we created a scRNA-seq analysis routine that recovers biologically relevant transcriptional activity beyond the scope of the best available genome annotation by performing scRNA-seq analysis on any region in the genome for which transcriptional products are detected. Our tool generates a single-cell expression matrix for all transcriptionally active regions (TARs), performs single-cell TAR expression analysis to identify biologically significant TARs, and then annotates TARs using gene homology analysis. This procedure uses single-cell expression analyses as a filter to direct annotation efforts to biologically significant transcripts and thereby uncovers biology to which scRNA-seq would otherwise be in the dark.


Patterns ◽  
2020 ◽  
Vol 1 (6) ◽  
pp. 100093
Author(s):  
Silu Huang ◽  
Charles Blatti ◽  
Saurabh Sinha ◽  
Aditya Parameswaran

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Kyle Ellrott ◽  
Alex Buchanan ◽  
Allison Creason ◽  
Michael Mason ◽  
Thomas Schaffter ◽  
...  

Abstract Challenges are achieving broad acceptance for addressing many biomedical questions and enabling tool assessment. But ensuring that the methods evaluated are reproducible and reusable is complicated by the diversity of software architectures, input and output file formats, and computing environments. To mitigate these problems, some challenges have leveraged new virtualization and compute methods, requiring participants to submit cloud-ready software packages. We review recent data challenges with innovative approaches to model reproducibility and data sharing, and outline key lessons for improving quantitative biomedical data analysis through crowd-sourced benchmarking challenges.


Sign in / Sign up

Export Citation Format

Share Document